Position in NKTR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$376,974
+$370,174 QoQ
Shares Held
5,400
+709.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#161
of 240 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,754,708 across 9 Biotechnology names. NKTR ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
551,583 | $4,329,926 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
28,000 | $2,434,600 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,696 | $1,681,063 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
293,417 | $1,666,608 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
54,675 | $925,101 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
151,846 | $631,679 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
20,225 | $378,409 | |
| 8 | NKTR |
Nektar Therapeutics
This page
|
5,400 | $376,974 |
All Filings in NKTR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $376,974 | 5,400 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $6,800 | 10,000 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $9,300 | 10,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,000 | 10,000 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $12,400 | 10,000 | Shares | Sole | 2024-07-18 | |
| No filing history on record for this holder in this stock. | ||||||